• 1. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Chlorobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Chlorobenzenes

Research Brief on 3-(4-chloro-3-methylphenyl)propan-1-ol (CAS: 1093173-25-1) in Chemical Biology and Pharmaceutical Applications

The compound 3-(4-chloro-3-methylphenyl)propan-1-ol (CAS: 1093173-25-1) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This aromatic alcohol derivative, characterized by its chloro-methylphenyl moiety, has shown promising potential in various therapeutic and synthetic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, particularly in the development of novel anti-inflammatory and anticancer agents. The structural versatility of this compound allows for further functionalization, making it a valuable scaffold in medicinal chemistry.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the pharmacokinetic properties of 3-(4-chloro-3-methylphenyl)propan-1-ol and its derivatives. The study highlighted its moderate bioavailability and metabolic stability, which are critical factors for drug development. Additionally, molecular docking simulations revealed that this compound exhibits affinity for several protein targets involved in inflammatory pathways, suggesting its potential as a lead compound for designing new anti-inflammatory drugs. These findings underscore the importance of further preclinical evaluations to assess its therapeutic efficacy and safety profile.

Another notable application of 3-(4-chloro-3-methylphenyl)propan-1-ol is its use in the synthesis of chiral ligands for asymmetric catalysis. A recent report in Organic Letters demonstrated its utility in the preparation of phosphine-oxazoline ligands, which were employed in highly enantioselective hydrogenation reactions. The study reported excellent yields and enantiomeric excesses, highlighting the compound's role in facilitating the production of optically active pharmaceuticals. This advancement is particularly relevant for the synthesis of complex molecules with stereochemical precision, a common requirement in modern drug design.

Despite its promising applications, challenges remain in the large-scale production and purification of 3-(4-chloro-3-methylphenyl)propan-1-ol. A 2024 study in Chemical Engineering Journal addressed these issues by developing a novel continuous-flow synthesis method, which improved yield and reduced byproduct formation. The optimized protocol not only enhances the compound's accessibility for research but also paves the way for its industrial-scale application. Future research directions may focus on exploring its biological activities in greater depth and expanding its utility in green chemistry initiatives.

In conclusion, 3-(4-chloro-3-methylphenyl)propan-1-ol (CAS: 1093173-25-1) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its dual role as a therapeutic intermediate and a chiral building block underscores its broad applicability. Continued investigations into its pharmacological properties and synthetic methodologies will likely uncover new opportunities for drug discovery and development, solidifying its position as a key player in the field.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)